Ro 24-7429

DB16062InvestigationalSmall molecule

Ro 24-7429 is under investigation in clinical trial NCT00002314 (A Study of Ro 24-7429 in Patients With Hiv-related Kaposi's Sarcoma).

Mechanism: Pharmacologically active on Runt-related transcription factor 1
Curator reviewed
Formula / weight: C₁₄H₁₃ClN₄ · 272.74 g/mol (avg)
Code names: RO-24-7429

Resolves to

Compound

Structure

InChIKeyLEAKQIXYSHIHCW-UHFFFAOYSA-NSMILESCNC1=NC2=C(C=C(Cl)C=C2)C(=NC1)C1=CC=CN1

Targets

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with Ro 24-7429, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.